Friday 4 September 2020

Reporting of a Subcutaneous Follicular Dendritic Cell Sarcoma Occurring in the Cheek | Chapter 7 | Current Topics in Medicine and Medical Research Vol.4

We report a subcutaneous follicular dendritic cell sarcoma (FDCS) in the cheek. Follicular dendritic

cell sarcoma is a rare neoplasm. Here we report the case of an 81-year-old woman presenting with

the chief complaint of swelling of the left cheek. We could only diagnose granulation tissue based on a

core-needle biopsy, thus, we decided to excise the tissue for definitive diagnosis. At first, we

considered a B-cell lymphoma, but the diagnosis of FDCS was made following immunostaining of

FDC markers. Tumor resection was performed without any other treatments such as

chemoradiotherapy. No recurrence has so far been detected for three years. In the head and neck,

FDCS occurs with a predilection for the tonsils. This appears to be the first report of a case of FDCS

occurring subcutaneously in the cheek. Currently, there are several options for treatment and can only

be standardized by accumulating experience with future cases.

 

Author (s) Details

Yohei Kawasaki

Department of Otorhinolaryngology, Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Teruyuki Sato

Department of Otorhinolaryngology, Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Yuko Hiroshima

Division of Clinical Pathology, Akita University Hospital, Akita, Japan.

Hiroshi Nanjo

Division of Clinical Pathology, Akita University Hospital, Akita, Japan.

Maya Suzuki

Department of Molecular and Tumor Pathology, Akita University Graduate School of Medicine, Akita, Japan.

Yasufumi Omori

Department of Molecular and Tumor Pathology, Akita University Graduate School of Medicine, Akita, Japan.

Takechiyo Yamada

Department of Otorhinolaryngology, Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan.

View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/248

 


No comments:

Post a Comment